T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Canadian Natural Resources
CNQ
|
$764M |
| 2 |
Cooper Companies
COO
|
$565M |
| 3 |
Martin Marietta Materials
MLM
|
$558M |
| 4 |
Thermo Fisher Scientific
TMO
|
$479M |
| 5 |
Lam Research
LRCX
|
$464M |
Top Sells
| 1 |
Ingersoll Rand
IR
|
$1.25B |
| 2 |
Xcel Energy
XEL
|
$889M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$858M |
| 4 |
KKR & Co
KKR
|
$625M |
| 5 |
NVIDIA
NVDA
|
$618M |
Sector Composition
| 1 | Technology | 23.04% |
| 2 | Healthcare | 19.81% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Financials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
BellRing Brands
BRBR
$5.11B
| $276M | 0.17% |
4,675,090
+971,483
| +26% | +$57.3M |
|
152
Treehouse Foods
THS
$910M
| $273M | 0.17% |
7,009,278
+733,504
| +12% | +$28.6M |
|
153
Boston Beer
SAM
$2.36B
| $271M | 0.17% |
890,717
-40,382
| -4% | -$12.3M |
|
154
Apellis Pharmaceuticals
APLS
$3.57B
| $271M | 0.17% |
4,605,721
-1,697,863
| -27% | -$99.8M |
|
155
Live Oak Bancshares
LOB
$1.72B
| $266M | 0.16% |
6,402,402
+36,572
| +0.6% | +$1.52M |
|
156
Selective Insurance
SIGI
$4.72B
| $265M | 0.16% |
2,427,792
-35,007
| -1% | -$3.82M |
|
157
Diamondback Energy
FANG
$43.3B
| $265M | 0.16% |
1,335,887
-131,923
| -9% | -$26.1M |
|
158
CAVA Group
CAVA
$7.62B
| $259M | 0.16% |
3,690,366
-7,467,465
| -67% | -$523M |
|
159
Magnolia Oil & Gas
MGY
$4.63B
| $256M | 0.16% |
9,884,124
+202,944
| +2% | +$5.27M |
|
160
SBA Communications
SBAC
$21.9B
| $255M | 0.16% |
1,178,359
+202,330
| +21% | +$43.8M |
|
161
Sarepta Therapeutics
SRPT
$1.81B
| $250M | 0.15% |
1,931,547
+11,805
| +0.6% | +$1.53M |
|
162
Chesapeake Utilities
CPK
$2.9B
| $243M | 0.15% |
2,267,249
+168,006
| +8% | +$18M |
|
163
Vaxcyte
PCVX
$4.08B
| $243M | 0.15% |
3,552,967
+2,306,926
| +185% | +$158M |
|
164
Popular Inc
BPOP
$8.41B
| $238M | 0.15% |
2,705,721
-46,020
| -2% | -$4.05M |
|
165
Arthur J. Gallagher & Co
AJG
$77B
| $238M | 0.15% |
950,271
+712,855
| +300% | +$178M |
|
166
Advanced Micro Devices
AMD
$259B
| $237M | 0.15% |
+1,313,800
| New | +$237M |
|
167
Mirion Technologies
MIR
$4.68B
| $235M | 0.14% |
20,641,440
+775,214
| +4% | +$8.81M |
|
168
Landstar System
LSTR
$4.54B
| $234M | 0.14% |
1,213,308
-46,400
| -4% | -$8.94M |
|
169
Markel Group
MKL
$24.4B
| $234M | 0.14% |
153,711
+1,491
| +1% | +$2.27M |
|
170
Meritage Homes
MTH
$5.43B
| $233M | 0.14% |
1,325,369
+146,013
| +12% | +$25.6M |
|
|
CTLT
171
DELISTED
CATALENT, INC.
CTLT
| $231M | 0.14% |
4,098,598
-7,110,776
| -63% | -$401M |
|
172
Reynolds Consumer Products
REYN
$4.86B
| $230M | 0.14% |
8,058,608
-10,056
| -0.1% | -$287K |
|
173
Entegris
ENTG
$12.2B
| $230M | 0.14% |
1,634,681
-162,352
| -9% | -$22.8M |
|
174
Atlassian
TEAM
$45.2B
| $230M | 0.14% |
1,176,844
-145,977
| -11% | -$28.5M |
|
175
Humana
HUM
$37.4B
| $228M | 0.14% |
656,938
+486,503
| +285% | +$169M |
|